Sort by 
Helus Pharma adds Dr. Robert Langer and Dr. Stephen Brannan to Scientific Advisory Board
Clinical-stage pharmaceutical company Helus Pharma has appointed renowned biotechnology pioneer Dr. Robert Langer and CNS drug development expert Dr. Stephen Brannan to its Scientific Advisory Board to advance its mental health pipeline.
Amneal Pharmaceuticals enters US commercial market with first inhalation products from Tipperary
Tipperary-based Amneal Pharmaceuticals has launched its first two metered-dose inhalation products on the US commercial market, marking a significant milestone for the Cashel facility and the wider Tipperary regional economy.
Helus Pharma partners with TARA Mind to support veteran recruitment for HLP003 trial
Helus Pharma has partnered with TARA Mind and Veterans Exploring Treatment Solutions to support veteran recruitment for the clinical-stage pharmaceutical company’s Phase 3 PARADIGM HLP003 programme for major depressive disorder.
Record Exports, Record Ambition: How GLP-1 Medicines Reshaped Ireland’s Pharmaceutical Landscape
Ireland’s pharmaceutical exports hit a record €139 billion in 2025, driven by surging GLP-1 medicine component production. The Goodbody Economic Report for IPHA sets an agenda for sustaining Ireland’s position as the EU’s second-largest pharmaceutical exporter.
Escaping Proof-of-Concept Purgatory: Ireland’s Biopharma Sector Confronts Its Generative AI Challenge
BioPharmaChem Ireland’s Generative AI for Life Sciences Playbook 2025 identifies proof-of-concept purgatory as the defining obstacle to AI adoption across Ireland’s biopharma sector. Over 100 validated use cases map a practical path from experimentation to production-scale value.
ABM Ireland named Gold Sponsor of Life Sciences Industry Awards 2026
ABM Ireland has been announced as Gold Sponsor of the Life Sciences Industry Awards 2026, bringing integrated facility and engineering services expertise to the programme ahead of the awards gala on 28 May at the Crowne Plaza Hotel, Santry. The partnership reflects ABM Ireland's alignment with organisations demonstrating excellence in innovation, operational standards, and sector leadership across Ireland's life sciences industry.
Crystal Pharmatech deploys first dedicated MicroED platform in Asia-Pacific region
China-based pharmaceutical CRO/CDMO Crystal Pharmatech has become the first company in the Asia-Pacific region to deploy a dedicated MicroED platform, advancing industrial-grade solid-state characterisation capabilities for global drug development clients.
Astellas closes Seattle stem cell therapy site in cell and gene therapy consolidation
Japanese pharmaceutical company Astellas is closing its Seattle stem cell therapy site as part of a wider consolidation of its cell, gene therapy, and oncology research operations, affecting approximately 55 employees.
Boehringer Ingelheim opens London AI centre with £150m ten-year investment
German pharmaceutical company Boehringer Ingelheim is launching an artificial intelligence and machine learning centre in London, committing £150 million over ten years to accelerate pharmaceutical research and drug discovery capabilities.
Helus Pharma appoints Eric So as interim chief executive following Michael Cola departure
Clinical-stage pharmaceutical company Helus Pharma has appointed co-founder and Executive Chairman Eric So as Interim Chief Executive Officer following the immediate departure of Michael Cola, while a permanent successor search is under way.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
.png)
